Inactive

This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) inten... This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to Illumina, Inc., San Diego, CA 92122 on a sole source basis to provide comprehensive maintenance service for the Illumina HiSeq 2500 Sequencer. The instrument is used for to perform high-throughput, next-generation sequencing to diagnose inherited immune disorders within the Department of Lab Medicine. The requirements for the HiSeq® 2500 Comprehensive Plan includes full coverage for parts, labor and travel; Reagent replacement upon HW failures; 1 PM; Remote Technical Support; 3 business day average on-site response; HW/SW updates; On-site applications support; Discounts on advanced training. This is the most popular full-service plan balancing performance, productivity and cost. Illumina is the sole manufacturer and is the only known provider with access to performance verified component parts, spare parts, software, technical support, upgrades and engineering resources to maintain the original operating specifications for the Illumina HiSeq 2500 sequencer. The parts and services for this instrument are not available from third party sources. Only Illumina service engineers have the technical expertise and skills to troubleshoot and repair this instrument. This acquisition is being conducted under the authority of the FAR Subpart 6.302-1 allowing the Contracting Officer (CO) to solicit from one source. The North American Industry Classification System (NAICS) code for this acquisition is 811219 with a large small business standard size of $20.5 million. This notice of intent to award is not a request for competitive quotations. Interested concerns capable of providing the same products or services as described in this notice may submit a capability statement outlining their capabilities. No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Each response should include the following Business Information: a. DUNS number and tax identification number. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Capability Statement Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Barbara Taylor, taylorb@cc.nih.gov by the due date and time marked in this notice.